About Genesis Innovation Group
Genesis is solely focused on medical device development. We are a family of industry experts that offer a platform of comprehensive services to support our customers during the entire innovation development lifecycle.
Our Vision
We will become the most respected and sought after medical device development company in the world.
Our Mission
We will collaborate with our customers to successfully develop and introduce innovative products that positively impact patient outcomes.
Our Strategic Advantage
We are a true Medical Device Development Company.
We provide a Highly Specialized Team of Experts.
We offer a Distinct Platform of Comprehensive Services and a mitigated, risk-based approach.
We deliver Execution Excellence and Results in a timely manner.
In the medical device development world, there is no other company like Genesis. Our combined team has more than a century of experience and over two hundred patents and innovations. Most importantly, our business model is the way forward – highly skilled, remote and efficient. In the simplest of terms, we quickly bring new ideas to life and create the future together.
Our Commitment and What You Can Expect from Genesis
Expertise
Our deeply experienced team offers a complete platform of medical device development services with a thorough understanding of every step, from ideation to commercialization.
Ingenuity
Clients know us for our ability to creatively overcome challenges, keep projects on track and uncover new ways to maximize the impact of their technology on the market.
Partnership
Genesis works in authentic partnership, side by side with entrepreneurs to both guide and support your vision. In addition, our strong relationships with researchers, manufacturers, distributors and physicians will expand your reach and accelerate development.
Created to Help Innovators
Genesis was founded by Rob Ball, Jeff Ondrla, and Don Running – longtime friends and successful medical device entrepreneurs. Leveraging their technical knowledge and experience, they created the company to meet the unique demands of early-stage medical device development by innovators with excellent ideas, but little experience in execution. Over time, a specialized team for the development of medical devices has evolved.
LEADERSHIP TEAM
Chance Leonard
Chief Executive Officer
Read Full Bio
Chance W. Leonard is the Chief Executive Officer at Genesis Innovation Group, Inc. and its subsidiary company Capitan Orthopedics, Inc. He brings more than 31 years of distinguished leadership experience in the medical device industry and a solidified reputation as a results-driven executive with expertise in orthopedic innovation, commercialization, and strategic growth. He is widely recognized for his deep industry knowledge, extensive relationships, and proven ability to build high-performing organizations that create significant enterprise value. Known for his influential, determined, and passionate leadership style, Mr. Leonard has consistently driven transformational growth across multiple high-profile orthopedic companies.
Most recently, Mr. Leonard served as Chief Commercial Officer at Skeletal Dynamics, where he played a pivotal role in building the company into a trusted global brand and establishing it as the premier upper extremity company worldwide. Under his leadership, Skeletal Dynamics achieved an extraordinary 330% growth in the U.S. market through execution excellence, a robust commercial strategy, integrated marketing and education initiatives, and a focused, organic portfolio development approach—resulting in substantial enterprise value creation.
Previously, Mr. Leonard served as Vice President at Stanmore Implants, where he successfully led the commercialization of the company’s U.S. platform in the highly competitive oncology and limb preservation market. His leadership and the efforts of his team were instrumental in Stanmore Implants’ acquisition by Stryker in April 2016. Earlier in his career, Mr. Leonard held key leadership roles at Zimmer Trauma and Synthes Trauma.
Mark Hanes
Senior Technical Director
Read Full Bio
Mark has over 20 years of orthopedic R&D experience spanning materials research, product testing, and product development. He has led the development and commercialization of over a dozen implant systems.
He has 8 issued patents and over 20 scientific publications.
Tyler Braketa
Vice President of Quality
Read Full Bio
Tyler has over 14 years of experience in the medical device industry, specializing in quality engineering and quality systems in orthopedics and electromechanical device space. His expertise includes implementing quality management systems, risk management and design control, and integrating quality processes.
Previously, Tyler held key quality leadership roles at Paragon 28, Zynex Medical and Zimmer Biomet Spine, where he drove initiatives to enhance and integrate quality systems across global teams for M&A, led recertification/FDA audits, and led cross-functional teams.
Board of Directors
Rob Ball
Read Full Bio
Rob has spent close to two decades bringing medical device technologies to market, including proprietary orthopedic materials.
He holds more than 30 issued or pending patents.
Jeff Ondrla
Read Full Bio
Jeff is a 25 year veteran of the orthopedic industry, having served in R&D roles for Zimmer, Depuy, DVO, and Tornier.
He is a prolific inventor with more than 50 issued or pending patents.
R. Sean Churchill
Read Full Bio
R. Sean Churchill, MD, MBA, serves as Managing Director of the cultivate(MD) Venture Capital Fund and is a Board Member of Genesis Innovation Group, Inc. and Capitan Orthopedics, Inc.. He brings a rare combination of clinical excellence, engineering expertise, and business acumen to the advancement of medical innovation. With more than 20 years of experience as a shoulder reconstruction specialist, Dr. Churchill has been at the forefront of orthopedic advancement since completing his formal training.
Dr. Churchill’s early career in chemical engineering provides him a unique approach to clinical problem-solving, enabling him to develop creative, practical, and scalable solutions to complex healthcare challenges. He is the inventor of the first FDA-approved stemless shoulder replacement and currently holds more than 20 issued and pending patents. His extensive innovation experience includes collaboration on 22 implant design teams, with product designs collectively responsible for more than $2 billion in global product sales since 2007.
In addition to his clinical and technical achievements, Dr. Churchill’s MBA provides him with a deep understanding of the business and financial dynamics of healthcare. This dual perspective is central to his leadership at cultivate(MD), where he plays a critical role in identifying, evaluating, and advancing high-potential medical technologies and startups. Dr. Churchill’s vision for cultivate(MD) extends beyond investment alone. He is committed to building a bridge between groundbreaking innovation and real-world clinical application—accelerating commercialization, reducing healthcare costs, and ultimately improving patient outcomes on a global scale.
Contact
Reach out to our team if you have a great idea that you think can serve the medical community.